Elon Musk announced that Neuralink’s first human brain-chip recipient has successfully recovered and can control a computer mouse with their thoughts. This milestone was shared during a social media event, highlighting the patient’s ability to navigate a mouse cursor on-screen merely by thinking. Neuralink, which began human trials last month following approval in September, aims to allow individuals to operate computers or keyboards through thought, employing a robot for the surgical implantation of brain-computer interface chips.
Musk’s vision for Neuralink extends to treating a range of conditions including obesity, autism, depression, and schizophrenia, with a focus on rapid and safe chip insertion. Despite the startup’s significant valuation and technological advances, it has encountered scrutiny over safety and regulatory compliance, including a recent fine for mishandling hazardous materials. The company’s progress in human trials marks a significant step forward in brain-computer interface technology.
Discover more from News Facts Network
Subscribe to get the latest posts sent to your email.
